Gene Therapy Market Size, Research, Analysis

1
Global Gene Therapy Market to Attain a CAGR of
34 During 2022-2031 Market to Grow on Account
of Increasing Prevalence of Cancer Cases and
Ethical Acceptance of Gene Therapy for Cancer
Treatment Kenneth Research published a report
titled Gene Therapy Market Global Demand
Analysis Opportunity Outlook 2031 which
delivers detailed overview of the gene therapy
in terms of market segmentation by indication,
technology, application, end user, and by
region. Further, for the in-depth analysis, the
report encompasses the industry growth
indicators, restraints, supply and demand risk,
along with detailed discussion on current and
future market trends that are associated with
the growth of the market. Request Sample Report
- https//www.kennethresearch.com/report-
details/gene-therapy-market/10070542 Increasing
prevalence of cancer cases, and ethical
acceptance of gene therapy for cancer treatment
are driving the need to adopt gene therapies. For
instance, according to the World Cancer Research
Fund, the cancer cases all over the world were
estimated to be 18.1 million in 2020, out of
which, 9.3 million cases were in men and 8.8
million in women. These key factors are
propelling the growth of the global gene therapy
market, which is estimated to garner
approximately USD 6 billion in revenue by 2031 by
growing at a CAGR of nearly 34 over the
forecast period, i.e., 2022 2031. The global
market is segmented by indication into cancer,
metabolic disorders, eye disorders,
cardiovascular diseases, and others. Among these
segments, the cancer segment is predicted to
hold the largest share of the market attributed
to increasing prevalence of several types of
cancers. For instance, according to the World
Cancer Research Fund, the most common cancers
worldwide are breast and lung cancers,
contributing 12.5 and 12.2, respectively, of
the total number of new cases diagnosed in
2020. Geographically, the global gene therapy
market is segmented into five major regions
including North America, Europe, Asia Pacific,
Latin America and Middle East Africa region.
Among these regions, the market in North America
region is estimated to hold the largest share of
the market and witness significant growth over
the forecast period. The factors driving the
market growth in the region are rapidly growing
cancer cases. For instance, according to the
Cancer
2
Facts Figures report, as of 2021, the estimated
number of new cancer cases diagnosed in the
United States was 1.9 million. Additionally,
Asia-Pacific is expected to witness the highest
CAGR during the forecast period. The research is
global in nature and covers detailed analysis on
the market in North America (U.S., Canada),
Europe (U.K., Germany, France, Italy, Spain,
Hungary, Belgium, Netherlands Luxembourg,
NORDIC Finland, Sweden, Norway, Denmark,
Poland, Turkey, Russia, Rest of Europe), Latin
America (Brazil, Mexico, Argentina, Rest of Latin
America), Asia-Pacific (China, India, Japan,
South Korea, Indonesia, Singapore, Malaysia,
Australia, New Zealand, Rest of Asia-Pacific),
Middle East and Africa (Israel, GCC Saudi
Arabia, UAE, Bahrain, Kuwait, Qatar, Oman,
North Africa, South Africa, Rest of Middle East
and Africa). In addition, analysis comprising
market size, Y-O-Y growth opportunity analysis,
market players competitive study, investment
opportunities, demand for future outlook etc. has
also been covered and displayed in the research
report. Request Sample Report -
https//www.kennethresearch.com/report-
details/gene-therapy-market/10070542 Rising
Awareness Regarding Benefits of Using Gene
Therapy as Compared to Traditional Therapy for
the Treatment of Various Diseases to Boost the
Market Growth The rising awareness regarding
benefits of using gene therapy as compared to
traditional therapy for the treatment of various
diseases is increasing the demand for gene
therapies. This is a key factor that is
anticipated to drive the growth of the market
during the forecast period. Additionally,
government support to promote gene therapy
related research, and increase in funding for
RD activities are further expected to boost the
market growth in upcoming years. However, high
operational costs associated with gene therapy
and unwanted immune responses are expected to
operate as key restraints to the growth of the
global gene therapy market over the forecast
period. This report also provides the existing
competitive scenario of some of the key players
of the global gene therapy market which includes
company profiling of Kineta, Inc., Novartis AG,
Amgen Inc., bluebird bio, Inc., Gilead Sciences,
Inc., Orchard Therapeutics plc, SIBIONO,
Questex, CRISPR Therapeutics, Editas Medicine,
and others.
3
The profiling enfolds key information of the
companies which encompasses business overview,
products and services, key financials and recent
news and developments. On the whole, the report
depicts detailed overview of the global gene
therapy market that will help industry
consultants, equipment manufacturers, existing
players searching for expansion opportunities,
new players searching possibilities and other
stakeholders to align their market centric
strategies according to the ongoing and expected
trends in the future. Request Sample Report -
https//www.kennethresearch.com/report-
details/gene-therapy-market/10070542 Kenneth
Research is a leading service provider for
strategic market research and consulting. We aim
to provide unbiased, unparalleled market insights
and industry analysis to help industries,
conglomerates and executives to take wise
decisions for their future marketing strategy,
expansion and investment etc. We believe every
business can expand to its new horizon, provided
a right guidance at a right time is available
through strategic minds. Our out of box thinking
helps our clients to take wise decision in order
to avoid future uncertainties. Contact for more
Info AJ Daniel Email sales_at_kennethresearch.com
U.S. Phone [phone]